Blood pressure is only one part of circulatory assessment.
What the paper found
The remimazolam–propofol comparison reported higher mean arterial pressure at selected points with remimazolam and a smaller difference in measured cardiac output. Recorded hypotension, injection pain and other adverse events also differed.
Limits of the evidence
A statistically clear difference at selected assessment points does not describe every minute of the procedure or establish a long-term outcome benefit. Results depend on measurement method, dosing and the selected population.
Implications for case review
Keep pressure and output separate rather than treating them as synonymous. For individual causation, assess baseline physiology, duration of changes, support and clinical consequences. The study cannot establish that a particular organ injury was prevented merely because one group had higher average measurements.
Source and related reading
Source: PMC12648994, supplied full-text paper. Findings are paraphrased; forensic implications are an interpretation.
Related: Gastroscopy Dose-Finding Still Required Propofol Rescue in Four of Twenty-Two Patients.
Leave a Reply